PharmaShots | Incisive News in 3 Shots

Subscribe Now

Salubris Biotherapeutics

Salubris Biotherapeutics Reports the EMA’s Approval to Conduct P-I Study of JK06 for Treating Solid Tumors

Salubris Biotherapeutics Reports the EMA’s Approval to Conduct P-I Study of JK06 for Treating Solid Tumors

August 5, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us